Therapeutic Asset Ratings

6,305 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
ab-201 Gastric Cancer	GC Cell Corporation	P1/2	CC (45)
Abatacept Recombinant Beta Thalassemia	National Heart, Lung, and Blood Institute (NHLBI)	P1/2	CC (45)
Abbv-453 Plasma Cell Myeloma	AbbVie	P1/2	CC (45)
Abemaciclib Brain Disorder	Stemline Therapeutics, Inc.	P1/2	CC (45)
Abemaciclib Breast Disorder	The Affiliated Hospital of Qingdao University	P1/2	CC (45)
Abemaciclib Malignant Glioma	Tango Therapeutics, Inc.	P1/2	CC (45)
Abemaciclib Breast Tumor Luminal A Or B	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	P1/2	CC (45)
Abemaciclib Prostate Adenocarcinoma	Vadim S Koshkin	P1/2	CC (45)
abx196 Hepatocellular Carcinoma	Abivax S.A.	P1/2	CC (45)
Acalabrutinib Glioblastoma	Acerta Pharma BV	P1/2	CC (45)
Ace-86225106 Breast-Ovarian Cancer, Familial, Susceptibility To, 1	Acerand Therapeutics (Shanghai) Limited	P1/2	CC (45)
Ace-86225106 BRCA2-Related Cancer Predisposition	Acerand Therapeutics (Shanghai) Limited	P1/2	CC (45)
Aclarubicin Sezary Syndrome	Shanghai Jiao Tong University School of Medicine	P1/2	CC (45)
ad1208 Neoplasm	Avelos Therapeutics Inc.	P1/2	CC (45)
Adv/Hsv-Tk Anaplastic Astrocytoma	The Methodist Hospital Research Institute	P1/2	CC (45)
AK 127 Cancer	Akeso	P1/2	CC (45)
ak129 Classic Hodgkin Lymphoma	Akeso	P1/2	CC (45)
Aleta-001 Diffuse Large B-Cell Lymphoma	Cancer Research UK	P1/2	CC (45)
Alintegimod Metastatic Neoplasm	7 Hills Pharma, LLC	P1/2	CC (45)
Alintegimod Skin Cancer	7 Hills Pharma, LLC	P1/2	CC (45)
Allocetra-Ots Peritoneum Cancer	Enlivex Therapeutics RDO Ltd.	P1/2	CC (45)
Allogeneic Adipose-Derived Mesenchymal Stem Cells Erectile Dysfunction	The Methodist Hospital Research Institute	P1/2	CC (45)
Allogeneic Cytomegalovirus-Specific T Cells Glioblastoma	Queensland Institute of Medical Research	P1/2	CC (45)
Allogeneic Human Umbilical Cord Blood Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome	The First Affiliated Hospital with Nanjing Medical University	P1/2	CC (45)
Aln-Sod Amyotrophic Lateral Sclerosis	Regeneron Pharmaceuticals	P1/2	CC (45)

Showing 2901 to 2925 of 6,305 assets

PreviousPage 117 of 253Next